Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase NA 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Unknown 1Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Lung Neoplasms 2Gliosarcoma 2Glioblastoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Tuberculosis, Pulmonary 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Rectal Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1Colonic Neoplasms 1Chordoma 1Breast Neoplasms, Male 1

Interventions

pembrolizumab 44Nivolumab 29Gemcitabine 28Paclitaxel 19Cisplatin 18Ipilimumab 15Carboplatin 14Cyclophosphamide 13Capecitabine 12Dexamethasone 10Bevacizumab 10cemiplimab 9Irinotecan 9Docetaxel 9Albumin-Bound Paclitaxel 9130-nm albumin-bound paclitaxel 9spartalizumab 8Pemetrexed 8Sorafenib 7Rituximab 7Cetuximab 7fludarabine 6Temozolomide 6Taxes 6Radiotherapy 6Leucovorin 6Fluorouracil 6Azacitidine 6Ascorbic Acid 6lenvatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT02130492 2026-05-15

A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

Weill Medical College of Cornell University

Phase 1/2 Suspended
30 enrolled
Tumor-Agnostic

Neoplasms

NCT05506566 2023-09-21

68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies

First Affiliated Hospital of Fujian Medical University

Phase 1/2 Unknown
50 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡